NCT00796159View on ClinicalTrials.gov

Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide

CompletedOBSERVATIONAL
Enrollment

1,723

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Hypertension
Interventions
DRUG

Olmesartan medoxomil

olmesartan medoxomil 20 mg and HCTZ 12.5 mg

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY